Remove Capital Remove Invest Remove Technology Remove Thousand Oaks
article thumbnail

Teledyne Invests In Optical Alchemy

socalTECH

Thousand Oaks-based Teledyne Technologies announced today that it has acquired a minority interest in Optical Alchemy , a Nashua, New Hampshire-based designer and manufacturer of ultra-light electro optical gimbal systems. Financial terms of the investment were not disclosed. READ MORE>>.

Invest 150
article thumbnail

Akriveia Therapeutics Raises $7.5M

socalTECH

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners. As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen Co-Founder Bowes Passes Away

socalTECH

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. USVP has backed such companies as Sun Microsystems, New Focus, Check Point Software Technologies, and hundreds of others.

article thumbnail

Amgen Gets Exit At Adheron Therapeutics

socalTECH

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. READ MORE>>.

article thumbnail

Teledyne Increases Stake in Robot Maker Ocean Aero

socalTECH

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Teledyne made its initial investment in Ocean Aero in July of 2014.

article thumbnail

Amgen Backs New $315M Life Sciences Fund

socalTECH

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio is focused on funding medicines and technologies with a focus on novel therapeutics for unmet medical needs. READ MORE>>.

article thumbnail

Interview with Brett Crosby and Brew Johnson, PeerStreet

socalTECH

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. We said, let's create a technology marketplace and platform that creates benefits for those existing lenders, as well as investors. So, we're focused on applying technology more efficiently and creating more value for investors.